One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1136/annrheumdis-2019-216118
Copy DOI Journal: Annals of the Rheumatic Diseases |  Publication Date: Nov 4, 2019 |
 Citations: 82 |  License type: open-access |
Affiliation: Université Paris Cité, Hôpital Cochin, Ghent University Hospital, Eli Lilly (United States), Chung Shan Medical University, Chung Shan Medical University Hospital, China Medical University, Charité - Universitätsmedizin Berlin, Brigham and Women's Hospital, Harvard University, University of Alberta, University of California, San Francisco, Oregon Health & Science University, University of Utah, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Leiden University Medical CenterObjectivesTo investigate the efficacy and safety of ixekizumab for up to 52 weeks in two phase 3 studies of patients with active radiographic axial spondyloarthritis (r-axSpA) who were biological disease-modifying...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
